M. Gail

R. Hoover, M. Gail, T. Fears, 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

OP-JNCI180109 158..169

W. Willett, N. Cook, E. Riboli, 2019 .

A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins.

M. Gail, L. Brown, R. Moslehi, 2006, The American journal of clinical nutrition.

Helicobacter pylori infection in rural China: exposure to domestic animals during childhood and adulthood.

M. Gail, L. Brown, W. You, 2001, Scandinavian journal of infectious diseases.

Case Series, Case Reports †

M. Gail, 2014 .

Re: Risk/benefit assessment of tamoxifen to prevent breast cancer-still a work in progress?

R. Croyle, M. Gail, J. Bryant, 2000, Journal of the National Cancer Institute.

A Method for Obtaining Short-Term Projections and Lower Bounds on the Size of the AIDS Epidemic

Mitchell H. Gail, Ron Brookmeyer, R. Brookmeyer, 1988 .

Projecting the incidence of AIDS.

M. Gail, 1990, JAMA.

The Minimum Size of the AIDS Epidemic in the United States

R. Brookmeyer, M. Gail, 1986 .

Helicobacter pylori prevalence and CagA status among children in two counties of China with high and low risks of gastric cancer.

M. Blaser, M. Gail, J. Fraumeni, 2001, Annals of epidemiology.

Associations between A -Tocopherol, B -Carotene, and Retinol and Prostate Cancer Survival

M. Gail, D. Albanes, J. Virtamo, 2009 .

Statistical Issues in Evaluation of Surrogate Endpoints

S. Zeger, M. Gail, V. Gruttola, 2000 .

Kin-cohort designs for gene characterization.

M. Gail, D. Pee, R. Carroll, 1999, Journal of the National Cancer Institute. Monographs.

The Background Review for the USPSTF Recommendation on Screening for Breast Cancer

M. Gail, C. Schairer, 2010 .

Biased estimates of treatment effect in randomized trials

M. Gail, S. Piantadosi, S. Wieand, 1984 .

Bias from Exposure Effects on Controls

M. Gail, 2005 .

METHODS FOR PROJECTING THE AIDS EPIDEMIC

R. Brookmeyer, M. Gail, 1987, The Lancet.

Errors-in-variables workshop.

M. Gail, D. Byar, 1989, Statistics in Medicine.

Discussion of "A formal causal interpretation of the case-crossover design" by Zach Shahn, Miguel A. Hernan, and James M. Robins.

M. Gail, Ruth M Pfeiffer, 2022, Biometrics.

Pilot study of induction therapy with cyclophosphamide, doxorubicin, and cisplatin (CAP) and chest irradiation prior to thoracotomy in initially inoperable stage III M0 non-small cell lung cancer.

M. Gail, P. Pairolero, R. Eagan, 1987, Cancer treatment reports.

Cardiovascular Risk Factors, Mortality, and Overweight—Reply

M. Gail, K. Flegal, D. Williamson, 2008 .

Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial

M. Gail, D. Lowy, J. Sampson, 2021, Vaccine.

COMMENT ON : VALIDATION OF THE GAIL ET AL. MODEL FOR PREDICTING INDIVIDUALBREAST CANCER RISK. AUTHORS' REPLY

G. Colditz, D. Spiegelman, J. Benichou, 1994 .

Increasing incidence of non-Hodgkin's lymphoma.

M. Gail, S. Devesa, S. Zahm, 1993, Seminars in hematology.

Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial.

M. Gail, D. Lowy, W. Quint, 2020, The Lancet. Oncology.

Projections of the number of persons diagnosed with AIDS and the number of immunosuppressed HIV-infected persons--United States, 1992-1994.

R. Brookmeyer, P. Rosenberg, M. Gail, 1992, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

Accommodating population differences when validating risk prediction models

M. Gail, D. Ankerst, Yiyao Chen, 2022, Statistics in Medicine.

Cell-substrate adhesivity. A determinant of cell motility.

M. Gail, C. Boone, Ch.W. Boone, 1972, Experimental cell research.

Predicting AIDS onset for individual patients.

J. Goedert, M. Gail, 1991, Clinical chemistry.

Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and prognosis after early-stage breast cancer

C. Ulrich, M. Gail, S. Mayne, 2011, Cancer Causes & Control.

Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts

W. Willett, N. Cook, E. Riboli, 2018, Journal of the National Cancer Institute.

Estimating vaccine effectiveness against SARS-CoV-2 infection, hospitalization and death from ecologic data in Costa Rica

M. Gail, R. Pfeiffer, A. Hildesheim, 2022, BMC Infectious Diseases.

Some Biases That May Affect Kin-Cohort Studies for Estimating the Risks from Identified Disease Genes

M. Gail, N. Chatterjee, 2004 .

Evaluation of durability of a single-dose of the bivalent HPV vaccine: the CVT Trial.

S. Chanock, M. Gail, D. Lowy, 2020, Journal of the National Cancer Institute.

Power Computations for Designing Comparative Poisson Trials

Mitchell H. Gail, M. Gail, 1974 .

Interplay between design and analysis for behavioral intervention trials with community as the unit of randomization.

M. Gail, B. Graubard, S. Green, 1995, American journal of epidemiology.

Association between tobacco use and the upper gastrointestinal microbiome among Chinese men

E. Vogtmann, Jianxin Shi, M. Gail, 2015, Cancer Causes & Control.

Radiation-induced thyroid neoplasms: evidence for familial susceptibility factors.

M. Gail, J. Lubin, D. Pee, 1988, The Journal of clinical endocrinology and metabolism.

Increasing efficiency and reducing bias when assessing HPV vaccination efficacy by using non-targeted HPV strains.

M. Gail, J. Sampson, Lola Étiévant, 2022, Biometrics.

Lifetime data analysis. Editorial.

M. Gail, David Harrington, 2008, Lifetime data analysis.

Association of Fecal Microbial Diversity and Taxonomy with Selected Enzymatic Functions

J. Goedert, Jianxin Shi, P. Gajer, 2012, PloS one.

A bibliography and comments on the use of statistical models in epidemiology in the 1980s.

M H Gail, M. Gail, 1991, Statistics in medicine.

Bias despite masked assessment of clinical outcomes when an outcome is defined as one of several component events.

M. Gail, S. Wacholder, J. Lubin, 1991, Controlled clinical trials.

Backcalculation of the number with human immunodeficiency virus infection in the United States.

J. Goedert, M. Gail, R. Biggar, 1991, American journal of epidemiology.

Predictive markers for the acquired immunodeficiency syndrome (AIDS) in hemophiliacs: persistence of p24 antigen and low T4 cell count.

J. Goedert, M. Gail, J. Drummond, 1989, Annals of internal medicine.

Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age.

J. Goedert, M. Gail, M. Eyster, 1987, Annals of internal medicine.

On Mendelian randomization analysis of case‐control study

Jing Qin, Kai Yu, Mitchell H Gail, 2019, Biometrics.

A molecular approach to the identification and individualization of human and animal cells in culture: Isozyme and allozyme genetic signatures

J. E. Shannon, S. O’Brien, M. Gail, 1980, In Vitro.

Value systems for comparing two independent multinomial trials

M. Gail, 1974 .

Early menopause in long-term survivors of cancer during adolescence

M. Gail, T. Fears, L. Strong, 1992 .

Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data.

M. Gail, J. Fraumeni, Jason Hu, 1998, Controlled clinical trials.

Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population.

M. Gail, P. Taylor, S. Dawsey, 1993, Journal of the National Cancer Institute.

Therapy may explain recent deficits in AIDS incidence.

J. Goedert, M. Gail, P. Rosenberg, 1990, Journal of acquired immune deficiency syndromes.

Methods for projecting course of acquired immunodeficiency syndrome epidemic.

R. Brookmeyer, M. Gail, 1988, Journal of the National Cancer Institute.

MINIMUM SIZE OF THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) EPIDEMIC IN THE UNITED STATES

Ron Brookmeyer, R. Brookmeyer, M. Gail, 1986, The Lancet.

Assessing risk model calibration with missing covariates.

Yei Eun Shin, M. Gail, R. Pfeiffer, 2021, Biostatistics.

Does cardiac transplantation prolong life? A reassessment.

M H Gail, M. Gail, 1972, Annals of internal medicine.

Haplotype analysis in population genetics and association studies.

Hongyu Zhao, Ruth Pfeiffer, Mitchell H Gail, 2003, Pharmacogenomics.

Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus.

J. Goedert, M. Gail, R. Biggar, 1987, JAMA.

Antiretroviral Therapy for Adult HIV-lnfected Patients: Recommendations From a State-of-the-Art Conference

R. Schooley, J. Phair, M. Hirsch, 1993 .

Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.

M. Gail, J. Fraumeni, L. Brown, 2006, Journal of the National Cancer Institute.

Spectrum of AIDS-associated malignant disorders

J. Goedert, E. Jaffe, M. Gail, 1998, The Lancet.

Average midrange ultraviolet radiation flux and time outdoors predict melanoma risk.

Mitchell H Gail, Allan Halpern, DuPont Guerry, 2002, Cancer research.

Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: the CVT Trial.

M. Gail, D. Lowy, W. Quint, 2020, Journal of the National Cancer Institute.

Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older.

M. Gail, W. McCaskill-Stevens, G. Anderson, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial.

M. Gail, C. Abnet, P. Taylor, 2009, Journal of the National Cancer Institute.

Human placental and pituitary glycoprotein hormones and their subunits as tumor markers: a quantitative assessment.

M. Gail, B. Weintraub, M. Blackman, 1980, Journal of the National Cancer Institute.

Cancer burden in the HIV-infected population in the United States.

J. Goedert, M. Gail, R. Pfeiffer, 2011, Journal of the National Cancer Institute.

Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men.

Jinbo Chen, M. Gail, S. Fosså, 2005, Journal of the National Cancer Institute.

Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China

S. Thorgeirsson, M. Gail, Zong-tang Sun, 2002, Hepatology.

Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer

M. Gail, J. Fraumeni, W. Blot, 1999, International journal of cancer.

Relationships between computer-extracted mammographic texture pattern features and BRCA1/2mutation status: a cross-sectional study

Hui Li, Li Lan, Claudia Giambartolomei, 2014, Breast Cancer Research.

Early side effects of intrathoracic BCG therapy in patients with stage I squamous cell carcinoma, adenocarcinoma, or large cell lung cancer

M. Gail, C. Mountain, E. Holmes, 1981, Cancer Immunology, Immunotherapy.

Immunological studies in a double blind randomized trial comparing intrapleural BCG against placebo in patients with resected stage I non-small cell lung cancer

M. Gail, W. Heineman, E. Holmes, 2004, Cancer Immunology, Immunotherapy.

Correlative genetic variation in natural populations of cats, mice and men

S. O’Brien, M. Gail, D. Levin, 1980, Nature.

Some of Sam Greenhouse's contributions to statistical methods

M. Gail, 2003, Statistics in Medicine.

Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China.

S. Thorgeirsson, M. Gail, Ju-Hyun Park, 2013, Carcinogenesis.

Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1

M. Gail, D. Pee, Zong-tang Sun, 1999, Hepatology.

Effects of α-tocopherol and β-carotene supplementation on liver cancer incidence and chronic liver disease mortality in the ATBC study

M. Gail, D. Albanes, J. Virtamo, 2014, British Journal of Cancer.

Association between Upper Digestive Tract Microbiota and Cancer-Predisposing States in the Esophagus and Stomach

Jianxin Shi, M. Gail, C. Abnet, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors.

M. Blaser, M. Gail, J. Fraumeni, 2000, Journal of the National Cancer Institute.

The promise and peril of surrogate end points in cancer research

M. Gail, A. Schatzkin, 2002, Nature Reviews Cancer.

Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study

X. Hua, Jianxin Shi, S. Chanock, 2016, PLoS medicine.

Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study

J. Goedert, Jianxin Shi, P. Gajer, 2012, Journal of Translational Medicine.

Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer

Gord Glendon, Lesley McGuffog, Daniel Barrowdale, 2012 .

Epidemiology and Biostatistics Program of the National Cancer Institute

J. Benichou, M. Gail, 1994 .

Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study.

X. Hua, J. Goedert, Jianxin Shi, 2015, Journal of the National Cancer Institute.

Fecal microbiota diversity in survivors of adolescent/young adult Hodgkin lymphoma: a study of twins

B. Nathwani, J. Goedert, M. Gail, 2012, British Journal of Cancer.

The association between the upper digestive tract microbiota by HOMIM and oral health in a population-based study in Linxian, China

Jianxin Shi, M. Gail, C. Abnet, 2014, BMC Public Health.

Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199).

M. Gail, M. Greene, M. Sherman, 2019, JNCI cancer spectrum.

Application of DNA fingerprints for cell-line individualization.

S. O’Brien, M. Gail, D. Pee, 1990, American journal of human genetics.

A Scale-Free Goodness-of-Fit Test for the Exponential Distribution Based on the Lorenz Curve

Joseph L. Gastwirth, Mitchell H. Gail, J. Gastwirth, 1978 .

On the robustness to measurement error of tests for exponentiality

J. Ware, M. Gail, 1978 .

Gail model for prediction of absolute risk of invasive breast cancer: independent evaluation in the Florence-European Prospective Investigation Into Cancer and Nutrition cohort.

Stefano Calza, Adriano Decarli, Mitchell H Gail, 2006, Journal of the National Cancer Institute.

Validation studies for models projecting the risk of invasive and total breast cancer incidence.

J Benichou, M H Gail, C K Redmond, 1999, Journal of the National Cancer Institute.

Transmission of HTLV-I and HIV among homosexual men in Trinidad.

W. Saxinger, M. Gail, R. Gallo, 1987, JAMA.

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.

M H Gail, R. Croyle, M. Gail, 1999, Journal of the National Cancer Institute.

Lung cancer prognosis before and after recurrence in a population-based setting.

M. Gail, S. Wacholder, M. Tucker, 2015, Journal of the National Cancer Institute.

Projecting individualized absolute invasive breast cancer risk in African American women.

Melissa Bondy, Giske Ursin, Mitchell H Gail, 2007, Journal of the National Cancer Institute.

Examining Video Self-Modeling in Promoting Food Acceptance in Children with Autism Spectrum Disorder in a School Setting

M. Gail, L. Rogers, 2014 .

Prevalence of Hepatitis C Virus Infection and Risk for Hepatocellular Carcinoma and Non‐Hodgkin Lymphoma in AIDS

J. Goedert, M. Gail, J. Lubin, 2002, Journal of acquired immune deficiency syndromes.

Validating and improving models for projecting the absolute risk of breast cancer.

M H Gail, M. Gail, J. Costantino, 2001, Journal of the National Cancer Institute.

Cancer risk prediction models: a workshop on development, evaluation, and application.

Andrew N Freedman, Mitchell H Gail, Graham A Colditz, 2005, Journal of the National Cancer Institute.

Evaluating breast cancer risk projections for Hispanic women

A. LaCroix, M. Gail, E. John, 2012, Breast Cancer Research and Treatment.

Breast Cancer Relative Hazard Estimates From Case–Control and Cohort Designs With Missing Data on Mammographic Density

Jinbo Chen, J. Benichou, M. Gail, 2008 .

A Prospective Study of Risk-Reducing Salpingo-oophorectomy and Longitudinal CA-125 Screening among Women at Increased Genetic Risk of Ovarian Cancer: Design and Baseline Characteristics: A Gynecologic Oncology Group Study

D. Alberts, M. Gail, L. Minasian, 2008, Cancer Epidemiology Biomarkers & Prevention.

The effect of vitamin and mineral supplementation on esophageal cytology: Results from the linxian dysplasia trial

M. Gail, P. Taylor, S. Dawsey, 1994, International journal of cancer.

Some of Nathan Mantel's contributions to epidemiology.

M. Gail, 1999, Statistics in medicine.

A conversation with Nathan Mantel

Mitchell H. Gail, M. Gail, 1997 .

A placebo-controlled randomized double-blind study of adjuvant intrapleural BCG in patients with resected T1N0, T1N1, or T2N0 squamous cell carcinoma, adenocarcinoma, or large cell carcinoma of the lung. LCSG Protocol 771.

M. Gail, 1994, Chest.

Sample Size Estimation When Time-to-Event is the Primary Endpoint

M. Gail, 1994 .

The Effect of Pooling Across Strata in Perfectly Balanced Studies

M. Gail, 1988 .

Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma.

M. Gail, E. Holmes, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of logrank tests and group sequential methods at fixed calendar times.

M H Gail, D L DeMets, D. DeMets, 1985, Biometrics.

A Randomized Comparison of the Effects of Adjuvant Therapy on Resected Stages II and III Non‐small Cell Carcinoma of the Lung

M. Gail, E. Holmes, L. Hill, 1985, Annals of surgery.

Monitoring rules for stopping accrual in comparative survival studies.

M. Gail, L. V. Rubinstein, L. Rubinstein, 1982, Controlled clinical trials.

Simulation Studies on Increments of the Two-Sample Logrank Score Test for Survival Time Data, with Application to Group Sequential Boundaries

Mitchell H. Gail, Eric V. Slud, David L. DeMets, 1982 .

Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation.

M H Gail, T J Santner, T. Santner, 1981, Journal of chronic diseases.

Confirmation of family cancer history reported in a population-based survey.

Mitchell H Gail, Barry I Graubard, Mark H Greene, 2011, Journal of the National Cancer Institute.

Procaine inhibition of fibroblast motility and proliferation.

M. Gail, C. Boone, Ch.W. Boone, 1972, Experimental cell research.

Assessment of the human faecal microbiota: II. Reproducibility and associations of 16S rRNA pyrosequences

J. Goedert, P. Gajer, M. Gail, 2012, European journal of clinical investigation.

Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women.

J. Goedert, M. Gail, H. Feigelson, 2014, The Journal of clinical endocrinology and metabolism.

Survival after AIDS diagnosis in a cohort of hemophilia patients. Multicenter Hemophilia Cohort Study.

J. Goedert, M. Gail, D. Pee, 1997, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology.

Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality.

M. Gail, J. Fraumeni, L. Brown, 2012, Journal of the National Cancer Institute.

Power of Microbiome Beta-Diversity Analyses Based on Standard Reference Samples.

Jianxin Shi, M. Gail, Yunhu Wan, 2020, American Journal of Epidemiology.

Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers.

J. Goedert, M. Gail, S. Weiss, 1988, Science.

Inference for covariates that accounts for ascertainment and random genetic effects in family studies

Mitchell H. Gail, Ruth M. Pfeiffer, David Pee, 2001 .

Neopterin: a predictive marker of acquired immune deficiency syndrome in human immunodeficiency virus infection.

W. Blattner, M. Gail, D. Fuchs, 1989, Journal of acquired immune deficiency syndromes.

National AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groups.

J. Goedert, P. Rosenberg, M. Gail, 1991, Journal of acquired immune deficiency syndromes.

Mammographic breast density and its association with urinary estrogens and the fecal microbiota in postmenopausal women

X. Hua, J. Goedert, Jianxin Shi, 2019, PloS one.

Feasibility of self-collection of fecal specimens by randomly sampled women for health-related studies of the gut microbiome

J. Goedert, M. Gail, H. Feigelson, 2014, BMC Research Notes.

Perspectives for Consideration in the Development of Microbial Cell Reference Materials

Emma Allen-Vercoe, Joseph Russell Carmical, Samuel P. Forry, 2019, Cancer Epidemiology, Biomarkers & Prevention.

Dave Byar's contribution to epidemiology.

M. Gail, 1995, Controlled clinical trials.

Population-based monitoring of an urban HIV/AIDS epidemic. Magnitude and trends in the District of Columbia.

M. E. Levy, J. Goedert, W. Blattner, 1992, JAMA.

Estimating HIV prevalence and projecting AIDS incidence in the United States: a model that accounts for therapy and changes in the surveillance definition of AIDS.

R. Carroll, P. Rosenberg, M. Gail, 1992, Statistics in medicine.

Uncertainty in estimates of HIV prevalence derived by backcalculation.

P. Rosenberg, M. Gail, 1990, Annals of epidemiology.

Levels of CD4+ lymphocytes, neopterin and ß2-microglobulin are early predictors of AIDS

J. Goedert, P. Rosenberg, M. Gail, 1990 .

Biases in prevalent cohorts.

R Brookmeyer, M H Gail, R. Brookmeyer, 1987, Biometrics.

Evaluating serial cancer marker studies in patients at risk of recurrent disease.

M H Gail, M. Gail, 1981, Biometrics.

Levels of CD4+ Lymphocytes, Neopterin, and β2-Microglobulin Are Early Predictors of Acquired Immunodeficiency Syndrome

J. Goedert, P. Rosenberg, M. Gail, 1990 .

The prevalent cohort study and the acquired immunodeficiency syndrome.

R. Brookmeyer, M. Gail, B. Polk, 1987, American journal of epidemiology.

Effect of colcemid on fibroblast motility.

M. Gail, C. Boone, Ch.W. Boone, 1971, Experimental cell research.

A nonparametric analysis of the transmission rate of human immunodeficiency virus from mother to infant.

J. Goedert, W. Tsai, M. Gail, 1994, Biometrics.

A Prospective Study of Red and Processed Meat Intake in Relation to Cancer Risk

R. Sinha, M. Gail, A. Schatzkin, 2007, PLoS medicine.

Using a Mixed Effects Model to Estimate Geographic Variation in Cancer Rates

M. Gail, G. Pennello, S. Devesa, 1999, Biometrics.

Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial

M. Gail, W. Blot, K. Pan, 2019, BMJ.

Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups.

M. Gail, J. Fraumeni, L. Brown, 2014, Journal of the National Cancer Institute.

Community intervention trial for smoking cessation (COMMIT): II. Changes in adult cigarette smoking prevalence.

M. Gail, B. Graubard, D. Corle, 1995, American journal of public health.

Relationships between computer-extracted mammographic texture pattern features and BRCA1/2mutation status: a cross-sectional study

Hui Li, Li Lan, Claudia Giambartolomei, 2014, Breast Cancer Research.

On Combining Data From Genome-Wide Association Studies to Discover Disease-Associated SNPs

Mitchell H. Gail, Ruth M. Pfeiffer, David Pee, 2009, 1010.5046.

Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women.

Mitchell H Gail, Regina G Ziegler, David Pee, 2011, Journal of the National Cancer Institute.

A Reminder of the Fallibility of the Wald Statistic

Mitchell H. Gail, Jacques Benichou, J. Benichou, 1996 .

Prenatal diethylstilbestrol exposure and cancer risk in women

R. Hoover, J. Palmer, M. Gail, 2019, Environmental and molecular mutagenesis.

Mendelian Randomization: How It Can—and Cannot—Help Confirm Causal Relations between Nutrition and Cancer

Ruth Pfeiffer, Amanda J. Cross, George Davey-Smith, 2009, Cancer Prevention Research.

Next steps in studying the human microbiome and health in prospective studies, Bethesda, MD, May 16–17, 2017

C. Huttenhower, H. Kong, E. Vogtmann, 2018, Microbiome.

Density inhibition of motility in 3T3 fibroblasts and their SV40 transformants.

M. Gail, C. Boone, 1971, Experimental cell research.

On meta-analytic assessment of surrogate outcomes.

R J Carroll, M H Gail, R Pfeiffer, 2000, Biostatistics.

Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies

S. Chanock, M. Gail, D. Lowy, 2018, Vaccine.

Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial

M. Gail, D. Lowy, W. Quint, 2018, Journal of the National Cancer Institute.

Design and statistical considerations for studies evaluating the efficacy of a single dose of the human papillomavirus (HPV) vaccine.

M. Gail, J. Sampson, A. Hildesheim, 2018, Contemporary clinical trials.

Re: Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.

M. Gail, L. Brown, W. You, 2001, Journal of the National Cancer Institute.

A review and critique of some models used in competing risk analysis.

M Gail, M. Gail, 1975, Biometrics.

Excess Deaths Associated With Underweight, Overweight, and Obesity: An Evaluation of Potential Bias.

Mitchell H Gail, Katherine M Flegal, Barry I Graubard, 2005, Vital & health statistics. Series 3, Analytical and epidemiological studies.

Piecewise exponential survival times and analysis of case‐cohort data

Dale L Preston, Jay H Lubin, Mitchell H Gail, 2012, Statistics in medicine.

Strategies for Developing Prediction Models From Genome‐Wide Association Studies

M. Gail, R. Pfeiffer, Jincao Wu, 2013, Genetic epidemiology.

Precancerous lesions in two counties of China with contrasting gastric cancer risk.

M. Gail, J. Fraumeni, W. Blot, 1998, International journal of epidemiology.

Alternative variance and efficiency calculations for the case-cohort design

Mitchell H. Gail, Sholom Wacholder, Ron Brookmeyer, 1989 .

EDITORIALS Validating and Improving Models for Projecting the Absolute Risk of Breast Cancer

M. Gail, J. Costantino, 2001 .

Ethical dilemmas in continuing a zidovudine trial after early termination of similar trials.

M. Gail, J. Bartlett, R. Redfield, 1993, Controlled clinical trials.

Helicobacter pylori infection in rural China: demographic, lifestyle and environmental factors.

M. Gail, L. Brown, D. Pee, 2002, International journal of epidemiology.

Validation of a model of lung cancer risk prediction among smokers.

Kathleen A Cronin, Mitchell H Gail, Peter B Bach, 2006, Journal of the National Cancer Institute.

Impact of smoking and preexisting illness on estimates of the fractions of deaths associated with underweight, overweight, and obesity in the US population.

M. Gail, K. Flegal, D. Williamson, 2007, American journal of epidemiology.

Sources of differences in estimates of obesity-associated deaths from first National Health and Nutrition Examination Survey (NHANES I) hazard ratios.

M. Gail, K. Flegal, D. Williamson, 2010, The American journal of clinical nutrition.

Two Approaches for Estimating Disease Prevalence from Population‐Based Registries of Incidence and Total Mortality

D. Midthune, M. Gail, L. Kessler, 1999, Biometrics.

Estimating the decision curve and its precision from three study designs

M. Gail, R. Pfeiffer, 2019, Biometrical journal. Biometrische Zeitschrift.

Postdiagnosis Diet Quality Is Inversely Related to a Biomarker of Inflammation among Breast Cancer Survivors

C. Ulrich, M. Gail, S. Mayne, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Secular stability and reliability of measurements of the percentage of dense tissue on mammograms.

J. Benichou, M. Gail, C. Schairer, 2003, Cancer detection and prevention.

Estrogen replacement therapy and breast cancer survival in a large screening study.

R. Hoover, P. Rosenberg, M. Gail, 1999, Journal of the National Cancer Institute.

The Need for Combined Assessment of Multiple Outcomes in Noninferiority Trials in Oncology.

M. Gail, I. Jatoi, 2019, JAMA oncology.

Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies.

Joshua LaBaer, Ann L Oberg, Christopher R Kinsinger, 2013, Journal of proteome research.

No impact of repeated endoscopic screens on gastric cancer mortality in a prospectively followed Chinese population at high risk.

M. Gail, R. Pfeiffer, B. Riecken, 2002, Preventive medicine.

Risk factor modification and projections of absolute breast cancer risk.

Adriano Decarli, Mitchell H Gail, Ruth M Pfeiffer, 2011, Journal of the National Cancer Institute.

Comparing strategies to estimate the association of obesity with mortality via a Markov model

Bingshu E. Chen, M. Gail, K. Flegal, 2011 .

Correcting Bias, or Biased Corrections?

M. Gail, K. Flegal, D. Williamson, 2008, Obesity.

Weight-associated deaths in the United States.

M. Gail, K. Flegal, D. Williamson, 2007, Journal of women's health.

On power and sample size for studying features of the relative odds of disease.

J H Lubin, M H Gail, M. Gail, 1990, American journal of epidemiology.

Response to “Biased Corrections or Biased About Corrections”

M. Gail, D. Williamson, B. Graubard, 2009, Obesity.

Estimation of attributable number of deaths and standard errors from simple and complex sampled cohorts

M. Gail, K. Flegal, D. Williamson, 2007, Statistics in medicine.

Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments

M. Gail, A. Achiron, Z. Rotstein, 2005, Breast Cancer Research and Treatment.

Biased selection of controls for case-control analyses of cohort studies.

J H Lubin, M H Gail, M. Gail, 1984, Biometrics.

On criteria for evaluating models of absolute risk.

Mitchell H Gail, Ruth M Pfeiffer, M. Gail, 2005, Biostatistics.

Comments on ‘Choice of time scale and its effect on significance of predictors in longitudinal studies’ by Michael J. Pencina, Martin G. Larson and Ralph B. D'Agostino, Statistics in Medicine 2007; 26:1343–1359

M. Gail, K. Flegal, D. Williamson, 2009, Statistics in medicine.

Encyclopedia of Epidemiologic Methods

Mitchell H. Gail, Jacques Benichou, J. Benichou, 2002 .

Estimates of absolute cause-specific risk in cohort studies.

J Benichou, M H Gail, J. Benichou, 1990, Biometrics.

Estimating Individualized Risk of Breast Cancer

J. Benichou, M. Gail, 1999 .

Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung.

M. Gail, T. Weisenburger, 1986, The New England journal of medicine.

The effect of cigarette smoking on the oral and nasal microbiota

J. Goedert, M. Gail, J. Ravel, 2017, Microbiome.

The Evaluation of Serial Marker Measurements for Monitoring Patients at Risk of Recurrent Cancer: Application to Colorectal Cancer

M. Gail, 1986 .

Association of surface ultraviolet B radiation levels with melanoma and nonmelanoma skin cancer in United States blacks.

M. Gail, G. Pennello, S. Devesa, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Maximizing DNA yield for epidemiologic studies: no more buffy coats?

M. García-Closas, M. Cosentino, Norma A. Diaz-Mayoral, 2013, American journal of epidemiology.

Should subcarinal lymph nodes be routinely examined in patients with non-small cell lung cancer? The Lung Cancer Study Group.

M. Gail, R. Ginsberg, S. Piantadosi, 1988, The Journal of thoracic and cardiovascular surgery.

Risk Assessment and Evaluation of Predictions

Tianxi Cai, Axel Gandy, Mitchell H. Gail, 2013 .

Pregnancy outcomes among mothers infected with human immunodeficiency virus and uninfected control subjects

M. Gail, P. Stratton, H. Minkoff, 1991 .

Methods of inference for estimates of absolute risk derived from population-based case-control studies.

J Benichou, M H Gail, J. Benichou, 1995, Biometrics.

Tests for no treatment e?ect in randomized clinical trials

M. H. Gail, M. Gail, S. Piantadosi, 1988 .

Associations between Biomarkers of Exposure and Lung Cancer Risk among Exclusive Cigarette Smokers in the Golestan Cohort Study

R. Malekzadeh, M. Gail, B. Xia, 2021, International journal of environmental research and public health.

Indirect corrections for confounding under multiplicative and additive risk models.

M. Gail, S. Wacholder, J. Lubin, 1988, American journal of industrial medicine.

Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention.

Sowmya R. Rao, M. Gail, W. McCaskill-Stevens, 2003, Journal of the National Cancer Institute.

Absolute Risk: Methods and Applications in Clinical Management and Public Health

Mitchell H. Gail, Ruth M. Pfeiffer, P. Bühlmann, 2018 .

Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening

M. Gail, R. Pfeiffer, 2018, Journal of the National Cancer Institute.

Case-Control Studies With Errors in Covariates

Mitchell H. Gail, Raymond J. Carroll, Jay H. Lubin, 1993 .

Applying the Lorenz curve to disease risk to optimize health benefits under cost constraints.

M. Gail, 2009, Statistics and its interface.

Introduction to Cornfield (1951) A Method of Estimating Comparative Rates from Clinical Data. Applications to Cancer of the Lung, Breast, and Cervix

Mitchell H. Gail, M. Gail, 1997 .

Associations between cancer and Parkinson's disease in U.S. elderly adults.

J. Goedert, M. Gail, N. Freedman, 2016, International journal of epidemiology.

Reproducibility studies and interlaboratory concordance for androgen assays in female plasma.

R. Hoover, M. Gail, T. Fears, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Screening geographic areas for unusual survival experience or stage at diagnosis with application to breast and colon cancer.

M. Gail, S. Piantadosi, D. Byar, 1985, Journal of the National Cancer Institute.

Weight calibration to improve efficiency for estimating pure risks from the additive hazards model with the nested case‐control design

Yei Eun Shin, M. Gail, B. Graubard, 2020, Biometrics.

Handbook of Statistical Methods for Case-Control Studies

Nilanjan Chatterjee, Mitchell H. Gail, Norman E. Breslow, 2018 .

Using standard microbiome reference groups to simplify beta-diversity analyses and facilitate independent validation

Marlena Maziarz, Mitchell H. Gail, Ruth M. Pfeiffer, 2018, Bioinform..

Comparative mortality for 621 second cancers in 29356 testicular cancer survivors and 12420 matched first cancers.

Bingshu E. Chen, M. Gail, S. Fosså, 2007, Journal of the National Cancer Institute.

A comparison of the power of two tests for qualitative interactions.

M H Gail, M. Gail, S. Piantadosi, 1993, Statistics in medicine.

On measures of agreement calculated from contingency tables with categories defined by the empirical quantiles of the marginal distributions.

M. Gail, C. Borkowf, 1997, American journal of epidemiology.

Helicobacter pylori infection and mode of transmission in a population at high risk of stomach cancer.

M. Gail, J. Fraumeni, L. Brown, 1998, International journal of epidemiology.

Circulating vitamin D and breast cancer risk: an international pooling project of 17 cohorts

Gretchen L. Gierach, N. Cook, M. McCullough, 2023, European Journal of Epidemiology.

Five-Year and Lifetime Risk of Breast Cancer among U.S. Subpopulations: Implications for Magnetic Resonance Imaging Screening

Andrew N Freedman, Mitchell H Gail, Barry I Graubard, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Population-density and county-level variation in breast cancer mortality rates among white women residing in the Northeastern and Southern United States

R. Hoover, M. Gail, B. Graubard, 2003, Cancer Causes & Control.

Twenty-five years of breast cancer risk models and their applications.

M. Gail, 2015, Journal of the National Cancer Institute.

Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features

J. Goedert, M. Gail, J. Ravel, 2016, Genome Biology.

Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival.

M. Gail, D. Albanes, J. Virtamo, 2009, Cancer research.

Improvements in US Breast Cancer Survival and Proportion Explained by Tumor Size and Estrogen-Receptor Status.

Mitchell H Gail, M. Gail, W. Anderson, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Backcalculation of flexible linear models of the human immunodeficiency virus infection curve.

M H Gail, P. Rosenberg, M. Gail, 1991, Journal of the Royal Statistical Society. Series C, Applied statistics.

Comparison of asbestos exposure assessments by next-of-kin respondents, by an occupational hygienist, and by a job-exposure matrix from the National Occupational Hazard Survey.

Jun-mo Nam, Mitchell H Gail, M. Gail, 2005, American journal of industrial medicine.

Haplotype Association Analysis

M. Gail, Peter Kraft, Jinbo Chen, 2008 .

Breast-cancer risk in BRCA-mutation-negative women from BRCA-mutation-positive families.

M. Gail, M. Greene, H. Katki, 2007, The Lancet. Oncology.

Critical Values for the One-Sided Two-Sample Kolmogorov-Smirnov Statistic

Mitchell H. Gail, M. Gail, S. Green, 1976 .

Design and analysis considerations for combining data from multiple biomarker studies

Molin Wang, Yue Song, Rebecca Betensky, 2018, Statistics in medicine.

A calcium requirement for fibroblast motility and prolifertion.

M. Gail, C. Boone, C. Thompson, 1973, Experimental cell research.

Cause-Specific Excess Deaths Associated With Underweight, Overweight, and Obesity

M. Gail, K. Flegal, D. Williamson, 2008 .

Serum Cytokine Analysis in a Positive Chemoprevention Trial: Selenium, Interleukin-2, and an Association with Squamous Preneoplastic Disease

M. Gail, P. Taylor, S. Dawsey, 2010, Cancer Prevention Research.

A factorial trial including garlic supplements assesses effect in reducing precancerous gastric lesions.

M. Gail, W. You, 2006, The Journal of nutrition.

Comparing breast cancer risk assessment models.

Mitchell H Gail, M. Gail, P. Mai, 2010, Journal of the National Cancer Institute.

How many controls?

D P Byar, M. Gail, D. Byar, 1976, Journal of chronic diseases.

Introduction. Errors‐in‐variables workshop

M. Gail, D. Byar, 1989 .

Designing studies to estimate the penetrance of an identified autosomal dominant mutation: Cohort, case‐control, and genotyped‐proband designs

M. Gail, R. Carroll, D. Pee, 1999, Genetic epidemiology.

The oral microbiome and lung cancer risk: An analysis of 3 prospective cohort studies.

E. Vogtmann, X. Hua, Jianxin Shi, 2022, Journal of the National Cancer Institute.

Simple examples should not be extrapolated to the US population

M. Gail, K. Flegal, B. Graubard, 2008, International Journal of Obesity.

LETTER TO THE EDITOR Simple examples should not be extrapolated to the US

Mitchell H. Gail, Km Flegal, Bi Graubard, 2008 .

The efficiency of the matched-pairs design of the Community Intervention Trial for Smoking Cessation (COMMIT).

M H Gail, D K Corle, S B Green, 1997, Controlled clinical trials.

Garlic, Vitamin, and Antibiotic Treatment for Helicobacter pylori: A Randomized Factorial Controlled Trial

M. Gail, L. Brown, R. Pfeiffer, 2007, Helicobacter.

Applicability of sample size calculations based on a comparison of proportions for use with the logrank test.

M H Gail, M. Gail, 1985, Controlled clinical trials.

Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia

S. Merajver, M. Gail, L. Brown, 2013, Cancer medicine.

Multiple markers for lung cancer diagnosis: validation of models for advanced lung cancer.

M H Gail, R. Elashoff, M. Gail, 1986, Journal of the National Cancer Institute.

Risk-based recommendations for mammographic screening for women in their forties.

M. Gail, B. Rimer, B Rimer, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Influence of Threonine Metabolism on S-Adenosylmethionine and Histone Methylation

M. Gail, A. Sica, A. Mantovani, 2013 .

On the use of laboratory markers as surrogates for clinical endpoints in the evaluation of treatment for HIV infection.

M. Gail, S. Ellenberg, S. G. Machado, 1990, Journal of acquired immune deficiency syndromes.

Helicobacter pylori infection, garlic intake and precancerous lesions in a Chinese population at low risk of gastric cancer.

M. Gail, J. Fraumeni, W. Blot, 1998, International journal of epidemiology.

Analysis of a Two‐Stage Case–Control Study with Cluster Sampling of Controls: Application to Nonmelanoma Skin Cancer

M. Gail, T. Fears, 2000, Biometrics.

Serum antibodies to Helicobacter pylori and the CagA antigen do not explain differences in the prevalence of precancerous gastric lesions in two Chinese populations with contrasting gastric cancer rates.

S. Lipsitz, M. Blaser, M. Gail, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Probability of helicobacter pylori infection based on IgG levels and other covariates using a mixture model.

M. Gail, L. Brown, R. Pfeiffer, 2000, Journal of epidemiology and biostatistics.

Reproducibility studies and interlaboratory concordance for assays of serum hormone levels: estrone, estradiol, estrone sulfate, and progesterone.

R. Hoover, M. Gail, T. Fears, 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Time lapse studies on the motility of fibroblasts in tissue culture.

M. Gail, 2008, Ciba Foundation symposium.

Pseudo‐likelihood estimates of the cumulative risk of an autosomal dominant disease from a kin‐cohort study

M. Gail, N. Chatterjee, D. Pee, 2001, Genetic epidemiology.

Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions

Bingshu E. Chen, M. García-Closas, P. Rosenberg, 2007, Cancer Causes & Control.

Validation of a colorectal cancer risk prediction model among white patients age 50 years and older.

Yikyung Park, Mitchell H Gail, Ruth M Pfeiffer, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gail model and breast cancer

M. Gail, M. Greene, 2000, The Lancet.

Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women

Mitchell H Gail, David Pee, Mandi Yu, 2017, Journal of the National Cancer Institute.

Eligibility exclusions, losses to follow-up, removal of randomized patients, and uncounted events in cancer clinical trials.

M. Gail, 1985, Cancer treatment reports.

Counting the Number of r×c Contingency Tables with Fixed Margins

Mitchell H. Gail, Nathan Mantel, M. Gail, 1977 .

A comparison of likelihood-based and marginal estimating equation methods for analysing repeated ordered categorical responses with missing data: application to an intervention trial of vitamin prophylaxis for oesophageal dysplasia.

M. Gail, S. Mark, 1994, Statistics in medicine.

Efficiency of DNA pooling to estimate joint allele frequencies and measure linkage disequilibrium

Joni L Rutter, Mitchell H Gail, Ruth M Pfeiffer, 2002, Genetic epidemiology.

Re: All-cause mortality in randomized trials of cancer screening.

M. Gail, H. Katki, 2002, Journal of the National Cancer Institute.

Familial aggregation of Hodgkin lymphoma and related tumors

M. Gail, J. Olsen, K. Hemminki, 2004, Cancer.

Sample size and power for case-control studies when exposures are continuous.

M. Gail, J. Lubin, A. Ershow, 1988, Statistics in medicine.

Robustness of risk-based allocation of resources for disease prevention

M. Gail, D. Pee, 2020, Statistical methods in medical research.

Choosing Breast Cancer Risk Models: Importance of Independent Validation.

M. Gail, 2020, Journal of the National Cancer Institute.

Comparison of two enzyme-linked immunosorbent assay tests for diagnosis of Helicobacter pylori infection in China.

M. Blaser, M. Gail, G. Perez-Perez, 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Are hospitals "keeping up with the Joneses"?: Assessing the spatial and temporal diffusion of the surgical robot.

Huilin Li, Mitchell H Gail, Cary P Gross, 2013, Healthcare.

Editors' note on the USPSTF recommendation on screening for breast cancer.

M. Gail, C. Schairer, 2010, Annals of internal medicine.

Comments and response on the USPSTF recommendation on screening for breast cancer.

M. Gail, C. Schairer, 2010, Annals of internal medicine.

The determination of sample sizes for use with the exact conditional test in 2 x 2 comparative trials.

J J Gart, J. Gart, M. Gail, 1973, Biometrics.

Testing for interaction in an I×J×K contingency table

J. Ware, M. Gail, N. Mantel, 1977 .

Increasing breast cancer incidence in China: the numbers add up.

M. Gail, R. Ziegler, W. Anderson, 2008, Journal of the National Cancer Institute.

The Analysis of Heterogeneity for Indirect Standardized Mortality Ratios

M. Gail, 1978 .

The Estimation and Use of Absolute Risk for Weighing the Risks and Benefits of Selective Estrogen Receptor Modulators for Preventing Breast Cancer

M. Gail, 2001, Annals of the New York Academy of Sciences.

Comparison of approaches for incorporating new information into existing risk prediction models

Nilanjan Chatterjee, Sonja Grill, Mitchell H Gail, 2017, Statistics in medicine.

Next steps in studying the human microbiome and health in prospective studies, Bethesda, MD, May 16–17, 2017

W. Willett, C. Huttenhower, H. Kong, 2018, Microbiome.

Predicting the Future of Genetic Risk Prediction

M. Gail, N. Chatterjee, Ju-Hyun Park, 2011, Cancer Epidemiology, Biomarkers and Prevention.

Beta‐diversity metrics of the upper digestive tract microbiome are associated with body mass index

E. Vogtmann, Jianxin Shi, M. Gail, 2015, Obesity.

Thoughts on “AIDS and COVID‐19: A Tale of Two Pandemics and the Role of Statisticians” by Susan S. Ellenberg and Jeffrey S. Morris

M. Gail, 2021, Statistics in medicine.

Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.

M. Gail, L. Brown, E. Fontham, 2000, Journal of the National Cancer Institute.

Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the General Population Trial in Linxian, China.

M. Gail, P. Taylor, S. Dawsey, 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Behavioral factors and SARS-CoV-2 transmission heterogeneity within a household cohort in Costa Rica

C. Viboud, M. Gail, K. Sun, 2022, Research square.

Time Lag Effect

M. Gail, 2005 .

Estimating the Absolute Risk of Disease Associated with Identified Mutations

M. Gail, N. Chatterjee, 2009 .

Score tests for familial correlation in genotyped‐proband designs

J. Benichou, M. Gail, D. Pee, 2000, Genetic epidemiology.

A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia.

J. Goedert, W. Blattner, M. Lederman, 1989, The New England journal of medicine.

Impact of Population Substructure on Trend Tests for Genetic Case–Control Association Studies

J. Gastwirth, Z. Li, M. Gail, 2010, Biometrics.